These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 6324996

  • 21. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 22. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
    Tsuchiya K, Uchida T, Kobayashi M, Maeda H, Konno T, Yamanaka H.
    Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
    [Abstract] [Full Text] [Related]

  • 23. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 24. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 25. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K, Obuchi M, Honda M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [Abstract] [Full Text] [Related]

  • 26. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
    [Abstract] [Full Text] [Related]

  • 27. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [Abstract] [Full Text] [Related]

  • 28. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
    Suzuki T, Kobayashi M, Nakamura T, Takahashi O, Imai K, Yamanaka H, Suzuki K, Konno T, Maeda H.
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct 20; 22(9):2210-7. PubMed ID: 2833546
    [No Abstract] [Full Text] [Related]

  • 29. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N, Sakakibara K, Itazu I, Hirai T, Nemoto A, Matsuura H, Kumada K, Nojiri O, Kano H.
    Semin Oncol; 1997 Apr 20; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [Abstract] [Full Text] [Related]

  • 30. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb 20; 25 Suppl 1():30-3. PubMed ID: 9512684
    [Abstract] [Full Text] [Related]

  • 31. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H, Onda M, Tajiri T, Uchida E, Arima Y, Mamada Y, Yamamoto K, Kaneko M, Terada Y, Kumazaki T.
    Hepatogastroenterology; 1999 Feb 20; 46(28):2612-5. PubMed ID: 10522050
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of carcinomatous effusion with oily anticancer agents dissolved in lipiodol].
    Kimura M, Konno T, Oda T, Yamashita R.
    Gan To Kagaku Ryoho; 1990 Aug 20; 17(8 Pt 2):1579-82. PubMed ID: 2167635
    [Abstract] [Full Text] [Related]

  • 33. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J, Hyodo I, Tanimizu M, Tanada M, Nishikawa Y, Hosokawa Y, Mandai K, Moriwaki S.
    Semin Oncol; 1997 Apr 20; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [Abstract] [Full Text] [Related]

  • 34. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
    Abe S, Yamasaki T, Nakano K, Yoshikawa I, Tabaru A, Otsuki M.
    J Gastroenterol; 2001 Jun 20; 36(6):415-21. PubMed ID: 11428589
    [Abstract] [Full Text] [Related]

  • 35. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
    Maki S, Konno T, Iwai K, Uchida M, Tashiro S, Miyauchi Y, Maeda H.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1443-9. PubMed ID: 6097616
    [No Abstract] [Full Text] [Related]

  • 36. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y, Nakamura H.
    Gan To Kagaku Ryoho; 1996 Jan 20; 23(1):99-101. PubMed ID: 8546478
    [Abstract] [Full Text] [Related]

  • 37. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.
    Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y.
    Cancer Chemother Pharmacol; 1992 Jan 20; 31 Suppl():S7-12. PubMed ID: 1333912
    [Abstract] [Full Text] [Related]

  • 38. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H, Sogabe M, Tsutsui A, Yokoi T, Morimoto M, Fukuda T, Hayashi S, Muguruma N, Ohkita Y, Okahisa T, Okamura S, Ito S.
    Gan To Kagaku Ryoho; 1998 Feb 20; 25 Suppl 1():133-40. PubMed ID: 9512701
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.